1.
Indian Heart J
;
1997 Mar-Apr; 49(2): 204-6
Article
in English
| IMSEAR
| ID: sea-4929
2.
Indian Heart J
;
1996 Nov-Dec; 48(6): 735-6
Article
in English
| IMSEAR
| ID: sea-3253
3.
Indian Heart J
;
1996 May-Jun; 48(3): 279-80
Article
in English
| IMSEAR
| ID: sea-3089
4.
Indian Heart J
;
1995 Sep-Oct; 47(5): 499-500
Article
in English
| IMSEAR
| ID: sea-3721
Subject(s)
Child , Heart Neoplasms/diagnosis , Humans , Male , Mitral Valve/surgery , Myxoma/diagnosis
5.
Article
in English
| IMSEAR
| ID: sea-16065
ABSTRACT
We studied the effect of atenolol 100 mg/day in 50 symptomatic patients of mitral stenosis and normal sinus rhythm, in a placebo controlled study. Atenolol caused significant bradycardia as compared to placebo (vitamin C; P < 0.001) without any adverse effects. It also increased exercise capacity significantly as compared to placebo (P < 0.001). All the patients were followed up to the period of 9 months and no adverse effects were seen. We conclude that beta adrenergic blocking drugs like atenolol can be used as the only treatment for patients with mitral stenosis without congestive heart failure and in sinus rhythm, for long-term symptomatic relief.
Subject(s)
Adolescent , Adult , Atenolol/therapeutic use , Female , Heart Rate/physiology , Humans , Male , Middle Aged , Mitral Valve Stenosis/drug therapy , Reference Values , Time Factors
6.
Indian Heart J
;
1985 Mar-Apr; 37(2): 128-30
Article
in English
| IMSEAR
| ID: sea-2909
Subject(s)
Adult , Echocardiography/methods , Female , Heart Atria , Heart Neoplasms/diagnosis , Humans , Myxoma/diagnosis
7.
Article
in English
| IMSEAR
| ID: sea-90999